Literature DB >> 9700947

Increased cyclin D1 expression in chronic pancreatitis.

M Kornmann1, T Ishiwata, N Arber, H G Beger, M Korc.   

Abstract

Cyclin D1 is an important regulator of the G1 phase of the cell cycle. In this study we examined the expression and localization of cyclin D1 in chronic pancreatitis (CP), a condition associated with fibrosis, acinar cell degeneration, and foci of duct cell proliferation. Northern blotting of total RNA from the normal pancreas and from the pancreas of patients with CP revealed the presence of a 4.4-kb cyclin D1 mRNA transcript in all samples. Densitometric analysis indicated that pancreatic cyclin D1 mRNA levels were 2.0-fold increased in CP compared to normal controls (p = 0.0046). In the normal pancreas, faint cyclin D1 immunoreactivity was present in the nuclei and cytoplasm of some ductal cells and islet cells. In contrast, in CP, moderate to strong cyclin D1 immunoreactivity was present in many ductal and islet cells, as well as in some acinar cells and fibroblasts. These findings raise the possibility that enhanced cyclin D1 expression may contribute to a hyperproliferative state in CP.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9700947     DOI: 10.1097/00006676-199808000-00008

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  8 in total

1.  Overexpression of caspase-1 in pancreatic disorders: implications for a function besides apoptosis.

Authors:  M Ramadani; F Gansauge; S Schlosser; Y Yang; H G Beger; S Gansauge
Journal:  J Gastrointest Surg       Date:  2001 Jul-Aug       Impact factor: 3.452

Review 2.  Oral nucleic acid therapy using multicompartmental delivery systems.

Authors:  Husain Attarwala; Murui Han; Jonghan Kim; Mansoor Amiji
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-05-24

3.  Overexpression of Caspase-1 in adenocarcinoma of pancreas and chronic pancreatitis.

Authors:  Yin-Mo Yang; Marco Ramadani; Yan-Ting Huang
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

4.  Oncogenic transformation of normal enterocytes by overexpression of cyclin D1.

Authors:  Diana Kazanov; Itzhak Shapira; Marjorie Pick; Olga Kolker; Eliezer Liberman; Varda Deutsch; Loudmilla Strier; Hadas Dvory-Sobol; Talya Kunik; Nadir Arber
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

5.  Immunohistochemical expression of cyclin D1, cyclin E, p21/waf1 and p27/kip1 in inflammatory bowel disease: correlation with other cell-cycle-related proteins (Rb, p53, ki-67 and PCNA) and clinicopathological features.

Authors:  Elli E Ioachim; Konstantinos H Katsanos; Michael C Michael; Epameinondas V Tsianos; Niki J Agnantis
Journal:  Int J Colorectal Dis       Date:  2004-04-02       Impact factor: 2.571

6.  Dual TNF-α/Cyclin D1 Gene Silencing With an Oral Polymeric Microparticle System as a Novel Strategy for the Treatment of Inflammatory Bowel Disease.

Authors:  Christina Kriegel; Mansoor M Amiji
Journal:  Clin Transl Gastroenterol       Date:  2011-03-24       Impact factor: 4.488

7.  The cyclin D1b splice variant: an old oncogene learns new tricks.

Authors:  Karen E Knudsen
Journal:  Cell Div       Date:  2006-07-24       Impact factor: 5.130

8.  Identification of potential serum exosomal microRNAs involved in acinar-ductal metaplasia that is a precursor of pancreatic cancer associated with chronic pancreatitis.

Authors:  Li-Ping Sheng; Chao-Qun Han; Chi Nie; Tao Xu; Kun Zhang; Xuan-Ji Li; Xin-Ru Xie; Rong Lin; Zhen Ding
Journal:  Medicine (Baltimore)       Date:  2021-05-07       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.